Moser U. Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a
therapeutic option for patients with central post-stroke pain syndrome? BMJ Case Rep 2021;14.
PMID: 34230048
![]() |
![]() |
![]() |
Free Medical Abstracts
Privacy Policy
Sponsors
Share
About
© Amedeo 1997-2016